SPA Weekly Update

April 21, 2006
IN THIS WEEK’S EDITION

NEWS/FUNDING OPPORTUNITIES

 

National Institutes of Health

NIH Announces Interim Changes to the PHS398 Application and Instructions

  • Click Here for revised forms (9/04): submissions prior to May 10, 2006
  • Click Here for revised forms (4/06): submissions on/after May 10, 2006

The PHS398 has been revised to incorporate a number of business process changes that have been implemented since the publication of the 9/2004 revision. Applicants should also review several other companion announcements available at: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-06-056.html.

Revised forms (dated rev. 4/06) and instructions are available for immediate use and are required for paper applications being prepared for submission/receipt dates on/after May 10, 2006. After this date, applications submitted using previous versions of form pages that have been updated, may be delayed in the review process.

NIH Announces Interim Changes to the PHS2590 Noncompeting Progress Report Forms and Instructions

  • Click Here for revised forms (9/04): submissions prior to June 1, 2006
  • Click Here for revised forms (4/06): submissions on/after June 1, 2006

The PHS2590 has been revised to incorporate a number of business process changes that have been implemented since the publication of the 9/2004 revision.Applicants should also review several other companion announcements available at: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-06-058.html.

Revised forms (dated rev. 4/06) and instructions are available and required for paper progress reports being prepared for due dates on/after June 1, 2006.

NIH Announces Change in Business Process: Replacing Principal Investigator Signature on Grant Applications, Progress Reports, and Prior Approval Requests with an Institutional Compliance Requirement

The signature of the Principal Investigator is no longer required as a part of a submitted application. Instead, a new compliance requirement is now implemented whereby the applicant organization agrees to secure and retain at the organization a written assurance from the Principal Investigator (PI) prior to submitting an application to the PHS. While this assurance is no longer required as part of the submitted application, it remains a compliance requirement. Therefore, organizations must retain a unique signature and date for each submitted application. This assurance must be available to the sponsoring agency or other authorized HHS or Federal officials upon request. Such an assurance must include at least the following certifications:

  1. that the information submitted within the application is true, complete and accurate to the best of the PI's knowledge;
  2. that any false, fictitious, or fraudulent statements or claims may subject the PI to criminal, civil, or administrative penalties; and
  3. that the PI agrees to accept responsibility for the scientific conduct of the project and to provide the required progress reports if a grant is awarded as a result of the application. When multiple PIs are proposed in an application, this assurance must be retained for all named PIs.

This change is effective with competing applications submitted for submission/receipt dates May 10, 2006 and thereafter. For more information, visit: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-06-054.html.

NIH/AHRQ Announce Change in Business Process Concerning eRA Commons Verifications of Electronically Submitted Applications

The original process for electronic submission of grant applications required that both the Signing Official (SO) and the Project Director/Principal Investigator (PD/PI) access the electronic grant application in the eRA Commons, check it for completeness, and verify it via a form checkbox. This verification served as the electronic signature for the application and completed the electronic submission process.

Effective for applications submitted for May 10, 2006 and beyond, NIH/AHRQ will no longer require the verification of the grant application by the AOR/SO and PD/PI. For more information, visit: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-06-055.html.

NIH Announces Changes to the SF424 (R&R) Instructions

The Application Guides for the SF424 (R&R) have been revised to incorporate a number of business process changes. Applicants should also review several other companion announcements available at: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-06-057.html.

Revised Application Guides are available for immediate use at: http://grants.nih.gov/grants/funding/424/index.htm.

Michael J. Fox Foundation

The Michael J. Fox Foundation for Parkinson's Research (http://www.michaeljfox.org/) has announced the launch of its 2006 Community Fast Track research program. This annual program aims to stimulate new and novel research that advances understanding of Parkinson's and accelerates improved treatments and an ultimate cure for PD patients.

Similar to last year's program, CFT '06 will support highly promising research projects conducted within a one-year timeframe and a $125,000 budget (a maximum of $100,000 direct costs plus a maximum of 25 percent indirect costs). The foundation anticipates awarding up to $2 million in total funding this year. Post-doctoral students or fellows are not eligible to apply as principal investigators for this RFA.

Letters of Intent Deadline: May 18, 2006

Complete program information and procedures for submitting Letters of Intent can be found at: http://fconline.fdncenter.org/pnd/10001798/michaeljfox

Children's Brain Tumor Foundation

The Children's Brain Tumor Foundation (http://cbtf.org/) is a national not-for-profit organization that seeks to improve the treatment, quality of life, and long-term outlook for children with brain and spinal cord tumors through research, support, education, and advocacy.

As a central component of its mission, CBTF awards grants for research into the causes of and effective treatments for pediatric brain and spinal cord tumors. Grants for the 2006 cycle will be in the amount of $150,000 and will be awarded over a two-year period.

Research grants will be for basic laboratory research on pediatric brain and CNS tumors. Funding is currently restricted to principal investigators at institutions within the U.S. and Canada.

Deadline: April 24, 2006 - Pre-Application Form

Submission of a pre-application form is required. Visit the CBTF Web site for complete grant program guidelines and a copy of the 2006 pre-application form at http://fconline.fdncenter.org/pnd/10001597/cbtf.


The Medical Foundation

The Medical Foundation's Research Grants Division administers eight programs for clients who support innovative research in the biomedical sciences, clinical investigation, and community health. For detailed information on individual programs and deadlines, visit: http://www.tmfnet.org/grantmake.html.


Archives - as of 03/22/06